Related Experiment Video
Updated: Mar 11, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.9K
[Chronic kidney disease and dyslipidaemia]
Vicente Pascual1, Adalberto Serrano2, Juan Pedro-Botet3
1Centro de Salud Palleter, Castellón, España.
Summary
Chronic kidney disease (CKD) is a high cardiovascular risk. Early intervention for dyslipidemia in CKD patients is crucial to reduce cardiovascular events and slow disease progression.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Chronic kidney disease (CKD) significantly elevates cardiovascular risk and mortality.
- Dyslipidemia accelerates CKD progression and atherosclerosis, increasing cardiovascular complications.
- Effective management of CKD and its comorbidities is essential for patient outcomes.
Purpose of the Study:
- To review lipid-lowering therapies for CKD patients.
- To emphasize early and intensive dyslipidemia management in CKD.
- To assess treatment adjustments based on disease progression and patient characteristics.
Main Methods:
- Literature review of therapeutic measures for dyslipidemia in CKD.
- Assessment of lipid-lowering strategies and their impact on cardiovascular events.
- Evaluation of treatment safety and efficacy, particularly statin therapy.
Main Results:
- Dyslipidemia control is vital for reducing cardiovascular morbidity and mortality in CKD.
- Early and intensive lipid management is a priority before significant kidney function decline.
- Statins are safe and effective for lowering LDL-Cholesterol and reducing cardiovascular events in CKD patients and post-transplant recipients, with less data for dialysis patients.
Conclusions:
- Optimizing lipid profiles in CKD patients is critical for cardiovascular risk reduction.
- Tailored lipid-lowering therapies, especially statins, should be implemented early in CKD management.
- Further research is needed on the efficacy of lipid-lowering treatments in dialysis patients.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
864
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
864
01:25Chronic Kidney Disease I: Introduction
936
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
936
01:28Chronic Kidney Disease III: Interprofessional Care
565
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
565
01:18Chronic Kidney Disease IV: Nursing Management
523
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
523
01:24Nephrotic Syndrome I : Introduction
801
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
801
01:24Overview of Lipid Metabolism
6.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.3K